Parenteral Drug Association
  

Add 2009 PDA/FDA Joint Regulatory Conference Course Series headlines to your news reader:

Click to view RSS Feed

Or, paste the URL in the box below into your preferred RSS reader.




2009 PDA/FDA Joint Regulatory Conference Course Series

Location: Washington, DC
Date: September 17-18, 2009
Time: All courses are 8:30 a.m. - 4:00 p.m., except 1.5 day courses end at noon on Friday, September 18.

Enhance your learning experience with Linked in

linked inLinked in members are encouraged to submit comments and start discussions about their training needs and/or goals in the 2009 PDA/FDA Joint Regulatory Conference group on Linked In. (For security purposes, you will have to request to join the group and be approved)

Available Courses

  • Quality by Design for Biopharmaceuticals: Concepts and Implementation – New Course!
    September 17, 2009
    Patrick Swann, PhD, Deputy Director, Division of Monoclonal Antibodies, OBP-OPS-CDER, FDA, and Anurag Rathore, PhD, Process Development, Amgen, Inc., will aim to clarify the key concepts that interplay in defining and implementing QbD towards manufacturing of biotech products.

  • Process Validation for Pharmaceuticals: Current and Future Trends
    September 17, 2009
    Scott Bozzone, PhD, Sr. Manager of Global Quality Operations – Validation, Pfizer, Inc.

  • GMP for Clinical Trial Materials: Regulations and Applications
    September 17, 2009
    This course will review the regulatory background associated with the manufacture of clinical trial materials, including FDA Guidance on the topic, and will also consider and discuss examples of how the regulations might be applied to the special situation of clinical trial material manufacture.
    Robert Dana, PDA
    Vince Mathews, Eli Lilly and Co.

  • Risk Management in Aseptic Processing
    September 17, 2008
    This course will provide the attendee with a background in risk management and aseptic process concepts, definitions, and regulatory expectations; as well as method for assessing, evaluating, controlling and communicating risk and related aspects of risk management.
    Hal Baseman, ValSource, LLC

  • Developing a Robust Supplier Control Process - New Course!
    September 17, 2009
    This workshop will discuss best methods for determining appropriate level of control for suppliers based on risk and developing assessment methods and continous monitoring tools.
    Lisa Hornback, Hornback Consulting, LLC

  • Qualification and Validation of API Manufacturing Operations
    September 17-18, 2009
    This is an in-depth one and one-half day workshop designed to give the participant a thorough foundation in the qualification and validation of all operations related to the production of Active Pharmaceutical Ingredients.
    Daniel Gold, PhD, D.H. Gold Associates

  • Preparing for Regulatory Inspections for the FDA and EMEA
    September 17-18, 2009
    The objective of this one and one-half day lecture course is to assist participants in the preparation to host an inspection, primarily focusing on EMEA GMP or pre-approval site inspections.
    David Chesney, PAREXEL Consulting

  • Contact
    Stephanie Ko
    PDA Training and Research Institute
    Manager, Lecture Education
    Tel: +1 (301) 656-5900 ext. 151
    Email: ko@pda.org

  • Location
    Renaissance Hotel
    999 9th Street, NW
    Washington, D.C. 20001
    +1 (202) 898-9000

 
From: 
Email:  
To: 
Email:  
Subject: 
Message: